hyperkalaemia


Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to hyperkalaemia: hypokalemia

hy·per·ka·le·mi·a

(hī'pĕr-kă-lē'mē-ă)
A greater than normal concentration of potassium ions in the circulating blood.
Synonym(s): hyperpotassemia, hyperkalaemia.
[hyper- + G. kalium, potash, + G. haima, blood]

hyperkalaemia

Excessive levels of potassium in the blood. This may be due to abnormally high intake of potassium supplements, kidney failure, circulatory failure, severe untreated DIABETES or other conditions. Excess potassium causes muscle weakness and paralysis, irregular heart action and CARDIAC ARREST.

hy·per·ka·le·mi·a

(hī'pĕr-kă-lē'mē-ă)
Higher than normal concentration of potassium ions in circulating blood.
Synonym(s): hyperkalaemia.
[hyper- + G. kalium, potash, + G. haima, blood]
References in periodicals archive ?
In our case, the sequence of events was probably development of prerenal failure due to the natriuretic effect of trimethoprim, resulting in further accumulation of trimethoprim and increasing the risk of hyperkalaemia.
Initially, in addition to treating hyperkalaemia and acidosis, replacement of salt wasting and rehdyration are also required.
The risk of hyperkalaemia in ACE-I treated patients is higher in patients with type II diabetes or renal insufficiency.
Bostock, "Nerve excitability changes in chronic renal failure indicate membrane depolarization due to hyperkalaemia," Brain, vol.
Metoprolol-induced hyperkalaemia in chronic respiratory acidosis.
The most frequent side effects/symptoms that nurses examined were hypertension (27), hypotension (23), bone disease (20), infection (13), pain (6), feet (6), fatigue (4), pruritus (4), inflammation (4) and hyperkalaemia (3).
The most common laboratory abnormalities noted among CKD patients were proteinuria, anaemia and hyperkalaemia. Advancing age, pre-existing morbidities such as diabetes mellitus, hypertension and overweight are characteristics that are strongly associated with the referred CKD patients.
Postoperatively, the patient was transferred to the Intensive Care Unit for 2 days and during his stay developed a metabolic acidosis with multiple episodes of hyperkalaemia. This was treated medically, and the patient's kidney function returned to baseline.
The takeover will give UK-based Astra-Zeneca access to a drug that could potentially treat the life-threatening condition hyperkalaemia.
It will give UK-based AstraZeneca access to a drug that could potentially treat the life-threatening condition hyperkalaemia. The drug, ZS-9, is currently under regulatory review by the US Food and Drug Administration.
Asi mismo, describimos el tipo de terapia empleada y se la comparo con las recomendaciones propuestas por la United Kingdom (UK) Renal Association (RA) en su Clinical Practice Guidelines Treatment of Acute Hyperkalaemia in Adults (3).
[K.sup.+] increases during the interdialytic interval and is removed during the HD session: therefore, HD patients often show hyperkalaemia at the beginning of the therapy and hypokalaemia at the end.